Wolchko J Scott — SEC Form 4 filings
SEC reporting owner CIK 1586893. 2 Form 4 filings on record with FilingPulse; latest filed 2024-02-02.
Transaction summary — filings shown
Covers all 2 filings on record, filed 2024-01-10 to 2024-02-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 14,391 shares, $62,889 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 1.
- Largest priced transaction: sale of 14,391 shares @ $4.37 ($62,889) in FATE THERAPEUTICS INC, filed 2024-01-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| FATE THERAPEUTICS INC (FATE) | President and CEO, Director | 2 | — | 1 leg · 14,391 sh · $62,889 | 1 |
Form 4 filings — Wolchko J Scott
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2024-02-02 | 4 | FATE THERAPEUTICS INC (FATE) | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2024-01-10 | 4 | FATE THERAPEUTICS INC (FATE) | Sale (S): 14,391 @ $4.37 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-10 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1586893 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →